Rite Aid, Quest Diagnostics expand COVID-19 test access

By LabPulse.com staff writers

July 19, 2022 -- Retail drugstore chain Rite Aid said on Tuesday that it is collaborating with Quest Diagnostics to expand access to COVID-19 molecular testing.

Through the collaboration, Quest PCR testing will be made available at more than 2,350 Rite Aid and Bartell Drugs stores.

"Our relationship with Rite Aid will extend our delivery of COVID-19 testing to more communities in the United States," Cathy Doherty, senior vice president of regional businesses at Quest Diagnostics, said in a statement.

Testing will be accessed through drive-through pharmacies or at-home specimen testing kits from stores without drive-through locations.

Quest Diagnostics launches monkeypox virus testing
Quest Diagnostics on Wednesday announced the availability of a lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox...
Quest sees June plateau in COVID-19 test demand
Quest Diagnostics said on Thursday that demand for its COVID-19 molecular diagnostic testing generally plateaued in June after rising in May.
Quest reports COVID-19 test demand rose in May
Quest Diagnostics said Wednesday that both demand and positivity rose steadily throughout May for its COVID-19 molecular diagnostic testing, but the pace...
Quest wins CDC contract for COVID population study
Quest Diagnostics recently received a contract granted by the U.S. Centers for Disease Control and Prevention (CDC) to test and analyze patterns in SARS-CoV-2...

Copyright © 2022 LabPulse.com

Last Updated mp 7/19/2022 12:15:46 PM